Metabolomics and Its Potential in Drug Discovery and Development From TCM

被引：4
作者：
Hang Chu [1 ]
Ai-Hua Zhang [1 ]
Ying Han [1 ]
Xi-Jun Wang [1 ]
机构：
[1] National TCM Key Lab of Serum Pharmacochemistry, Key Laboratory of Metabolomics and Chinmedomics, Department of Pharmaceutical Analysis,Heilongjiang University of Chinese Medicine
来源：
World Journal of Traditional Chinese Medicine | 2015年 / 1卷 / 04期
基金：
黑龙江省自然科学基金;
关键词：
Metabolomics; traditional Chinese medicine; formulae; biomarker; drug discovery;
D O I：
暂无
中图分类号：
R28 [中药学];
学科分类号：
1008 ;
摘要：
Metabolomics, an omic science in systems biology, is the comprehensive profiling of metabolic changes occurring in living systems and has been widely used in the modern research of traditional Chinese medicine(TCM). TCM is a complex medical science, which reflects rich philosophical dialectical thought, puts the human body into a large system for observation and keeps human in a healthy status. For TCM aroused great interest in the whole world, herbs and Chinese medical formulae(CMF) as treatment methods have also been widely attention.Metabolomics represents a powerful way that provides a dynamic drawing of the phenotype of biological systems via the research of endogenous metabolites, and its methods are similar to those of TCM. This review summarizes the advantages of metabolomics, highlight the key role of biomarkers for drug discovery and development of TCM.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 50 条
  • [41] Stable isotope-resolved metabolomics and applications for drug development
    Fan, Teresa W. -M.
    Lorkiewicz, Pawel K.
    Sellers, Katherine
    Moseley, Hunter N. B.
    Higashi, Richard M.
    Lane, Andrew N.
    PHARMACOLOGY & THERAPEUTICS, 2012, 133 (03) : 366 - 391
  • [42] Alternative splicing as a biomarker and potential target for drug discovery
    Kai-qin Le
    Bellur S Prabhakar
    Wan-jin Hong
    Liang-cheng Li
    Acta Pharmacologica Sinica, 2015, 36 : 1212 - 1218
  • [43] Radiation metabolomics and its potential in biodosimetry
    Coy, Stephen L.
    Cheema, Amrita K.
    Tyburski, John B.
    Laiakis, Evagelia C.
    Collins, Sean P.
    Fornace, Albert J., Jr.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2011, 87 (08) : 802 - 823
  • [44] Alternative splicing as a biomarker and potential target for drug discovery
    Le, Kai-qin
    Prabhakar, Bellur S.
    Hong, Wan-jin
    Li, Liang-cheng
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (10) : 1212 - 1218
  • [45] Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug discovery
    Fall, Fanta
    Mamede, Lucia
    Schioppa, Laura
    Ledoux, Allison
    De Tullio, Pascal
    Michels, Paul
    Frederich, Michel
    Quetin-Leclercq, Joelle
    METABOLOMICS, 2022, 18 (04)
  • [46] Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug discovery
    Fanta Fall
    Lucia Mamede
    Laura Schioppa
    Allison Ledoux
    Pascal De Tullio
    Paul Michels
    Michel Frédérich
    Joëlle Quetin-Leclercq
    Metabolomics, 18
  • [47] Recent advances from metabolomics and lipidomics application in alzheimer?s disease inspiring drug discovery
    Cuperlovic-Culf, Miroslava
    Badhwar, Amanpreet
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (03) : 319 - 331
  • [48] Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential
    Tunon, Jose
    Barbas, Coral
    Blanco-Colio, Luis
    Burillo, Elena
    Lorenzo, Oscar
    Luis Martin-Ventura, Jose
    Mas, Sebastian
    Javier Ruperez, Francisco
    Egido, Jesus
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (09) : 857 - 871
  • [49] Thiazole Heterocycle: An Incredible and Potential Scaffold in Drug Discovery and Development of Antitubercular Agents
    Bhanwala, Neeru
    Gupta, Vaibhav
    Chandrakar, Lokesh
    Khatik, Gopal L.
    CHEMISTRYSELECT, 2023, 8 (46):
  • [50] Role of drug metabolism in drug discovery and development
    Kumar, GN
    Surapaneni, S
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (05) : 397 - 411
12345